NeuraLight
3 known investors
NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.
Founders & leadership
E
Eddy
G
Gil
PT
Prof. Thomas Südhof
PO
Prof. Olivier Rascol
Investors · 3
In the news
- NeuraLight — Health Tech & Life Sciences | Finderfinder.startupnationcentral.org · 2023
- Israeli Startup NeuraLight Raises $25M For Its AI Neurological Platformnocamels.com · 2022
- NeuraLight secures $25 million Series A to develop precision medicine for neurological diseases | CTechcalcalistech.com · 2022
- NeuraLight launches from stealth, raises $5.5 million to digitize neurology - CTechcalcalistech.com · 2021
- NeuraLight Raises $5.5M in Seed Funding - FinSMEsfinsmes.com · 2021
- NeuraLight emerges from stealth with $5.5M to digitize neurological evaluation and care | TechCrunchtechcrunch.com · 2021